Gulsen Ozen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Venous Thromboembolism

Rheumatoid Arthritis

Arabidopsis Thaliana

Top Venues

Annals of the rheumatic diseases

The Journal of rheumatology

Arthritis care & research

This page only lists publications with an associated author ORCID identifier.

Publications

Gulsen Ozen, Sofia Pedro, Kaleb D Michaud
Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Gulsen Ozen, Sophie Dell'Aniello, Sofia Pedro, Kaleb D Michaud, Samy Suissa
Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid Arthritis. Arthritis care & research (2022)
Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, Teresa A Simon, Kaleb D Michaud
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis? RMD open 7 (2) (2021)
Gulsen Ozen, Sofia Pedro, Kaleb D Michaud
The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. The Journal of rheumatology 48 (5) (2020)
Gulsen Ozen, Sofia Pedro, Frederick Wolfe, Kaleb D Michaud
Medications associated with fracture risk in patients with rheumatoid arthritis. Annals of the rheumatic diseases 78 (8) (2019)
Gulsen Ozen, Kaleb D Michaud
Response to: 'Medications associated with fracture risk in patients with rheumatoid arthritis' by Chen et al. Annals of the rheumatic diseases 80 (9) (2019)
Gulsen Ozen, Sofia Pedro, Bryant R England, Bella Mehta, Frederick Wolfe, Kaleb D Michaud
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs. ACR open rheumatology 1 (7) (2019)